BRAF and thyroid cancer, nonmedullary, 2: A single human study found the RAS oncogene mutation rate was higher in FTC cases from an iodine deficient area, and in the two human studies investigating the BRAF mutation in PTC, one found no increased occurrence in cases from an iodine deficient area population while another found an increased occurrence in an iodine excess area.